CLINICAL_TRIALS
trial_result
· 2019-02-27
Clinical Trial Update: A Comparison of the Safety, PD and PK of a Single Dose of SYN023 Administered With Licensed Rabies Vaccines [Phase 1, Phase 2]
Summary
Phase 1/2 clinical trial update evaluating safety, pharmacodynamics, and pharmacokinetics of a single dose of SYN023 with licensed rabies vaccines in human rabi…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Synermore Biologics Co., Ltd. | Conditions: Human Rabies | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-02-27